|
1
|
Bodey GP: Infection in cancer patients. A
continuing association. Am J Med. 81:11–26. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Martel C and Franceschi S: Infections
and cancer: Established associations and new hypotheses. Crit Rev
Oncol Hematol. 70:183–194. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Foerster R, Davalos-Misslitz AC and Rot A:
CCR7 and its ligands: Balancing immunity and tolerance. Nat Rev
Immunol. 8:362–371. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Foerster R, Schubel A, Breitfeld D,
Kremmer E, Renner-Müller I, Wolf E and Lipp M: CCR7 coordinates the
primary immune response by establishing functional
microenvironments in secondary lymphoid organs. Cell. 99:23–33.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brandman JR, Ruckdeschel JC, O'Donnell MR
and Horton J: Small cell cancer of lung; rapid tumor necrosis
leading to serious pulmonary infections after intensive
chemotherapy. NY State J Med. 81:1332–1334. 1981.
|
|
6
|
Vento S, Cainelli F and Ternesgen Z: Lung
infections after cancer chemotherapy. Lancet Oncol. 9:982–992.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vento S and Cainelli F: Infections in
patients with cancer undergoing chemotherapy: Aetiology,
prevention, and treatment. Lancet Oncol. 4:595–604. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
De Visser KE, Schumacher TNM and Kruisbeek
AM: CD8(+) T cell tolerance and cancer immunotherapy. J Immunother.
26:1–11. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Marchant A and Goldman M: T cell-mediated
immune responses in human newborns: Ready to learn? Clin Exp
Immunol. 141:10–18. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Day TA, Koch M, Nouailles G, Jacobsen M,
Kosmiadi GA, Miekley D, Kuhlmann S, Jörg S, Gamradt P, Mollenkopf
HJ, et al: Secondary lymphoid organs are dispensable for the
development of T-cell-mediated immunity during tuberculosis. Eur J
Immunol. 40:1663–1673. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mueller SN, Hosiawa-Meagher KA, Konieczny
BT, Sullivan BM, Bachmann MF, Locksley RM, Ahmed R and Matloubian
M: Regulation of homeostatic chemokine expression and cell
trafficking during immune responses. Science. 317:670–674. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao L, Liu L, Guo B and Zhu B: Regulation
of adaptive immune responses by guiding cell movements in the
spleen. Frontiers Microbiol. 6:2015. View Article : Google Scholar
|
|
13
|
Siegert S and Luther SA: Positive and
negative regulation of T cell responses by fibroblastic reticular
cells within paracortical regions of lymph nodes. Front Immunol.
3:2852012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Malhotra D, Fletcher AL, Astarita J,
Lukacs-Kornek V, Tayalia P, Gonzalez SF, Elpek KG, Chang SK,
Knoblich K, Hemler ME, et al: Transcriptional profiling of stroma
from inflamed and resting lymph nodes defines immunological
hallmarks. Nat Immunol. 13:499–510. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cesta MF: Normal structure, function, and
histology of the spleen. Toxicol Pathol. 34:455–465. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
den Haan JM, Mebius RE and Kraal G:
Stromal cells of the mouse spleen. Front Immunol.
3:2012012.PubMed/NCBI
|
|
17
|
Luther SA, Bidgol A, Hargreaves DC,
Schmidt A, Xu Y, Paniyadi J, Matloubian M and Cyster JG: Differing
activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in
lymphocyte and dendritic cell recruitment and lymphoid neogenesis.
J Immunol. 169:424–433. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bajenoff M, Egen JG, Koo LY, Laugier JP,
Brau F, Glaichenhaus N and Germain RN: Stromal cell networks
regulate lymphocyte entry, migration, and territoriality in lymph
nodes. Immunity. 25:989–1001. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bepler G, Kusmartseva I, Sharma S, Gautam
A, Cantor A, Sharma A and Simon G: RRM1 modulated in vitro and in
vivo efficacy of gemcitabine and platinum in non-small-cell lung
cancer. J Clin Oncol. 24:4731–4737. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Barry MA, Behnke CA and Eastman A:
Activation of programmed cell death (apoptosis) by cisplatin, other
anticancer drugs, toxins and hyperthermia. Biochem Pharmacol.
40:2353–2362. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vincent J, Mignot G, Chalmin F, Ladoire S,
Bruchard M, Chevriaux A, Martin F, Apetoh L, Rébé C and
Ghiringhelli F: 5-Fluorouracil selectively kills tumor-associated
myeloid-derived suppressor cells resulting in enhanced T
cell-dependent antitumor immunity. Cancer Res. 70:3052–3061. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao L, Gao J, Li Y, Liu L, Yang Y, Guo B
and Zhu B: Disrupted homeostatic cytokines expression in secondary
lymph organs during HIV infection. Int J Mol Sci. 17:4132016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao L, Chen J, Liu L, Gao J, Guo B and
Zhu B: Essential role of TNF-alpha in development of spleen
fibroblastic reticular cells. Cell Immunol. 293:130–136. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shitara K, Matsuo K, Oze I, Mizota A,
Kondo C, Nomura M, Yokota T, Takahari D, Ura T and Muro K:
Meta-analysis of neutropenia or leukopenia as a prognostic factor
in patients with malignant disease undergoing chemotherapy. Cancer
Chemother Pharmacol. 68:301–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bruserud O, Bergheim J, Shammas FV and
Nesthus I: Serum concentrations of tumour necrosis factor-alpha
during chemotherapy-induced leukopenia in patients with acute
leukaemia and bacterial infections. Leuk Res. 18:415–421. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
De Togni P, Goellner J, Ruddle NH,
Streeter PR, Fick A, Mariathasan S, Smith SC, Carison R, Shonnick
LP, Strauss-Schoenberger J, et al: Abnormal development of
peripheral lymphoid organs in mice deficient in lymphotoxin.
Science. 264:703–707. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Stranford S and Ruddle NH: Follicular
dendritic cells, conduits, lymphatic vessels, and high endothelial
venules in tertiary lymphoid organs: Parallels with lymph node
stroma. Frontiers Immunol. 3:3502012. View Article : Google Scholar
|
|
29
|
Bronte V and Pittet MJ: The spleen in
local and systemic regulation of immunity. Immunity. 39:806–818.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao L, Liu L, Gao J, Yang Y, Hu C, Guo B
and Zhu B: T lymphocytes maintain structure and function of
fibroblastic reticular cells via lymphotoxin (LT)-B. BMC Immunol.
15:33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Malhotra D, Fletcher AL and Turley SJ:
Stromal and hematopoietic cells in secondary lymphoid organs:
Partners in immunity. Immunol Rev. 251:160–176. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Turley SJ, Fletcher AL and Elpek KG: The
stromal and haematopoietic antigen-presenting cells that reside in
secondary lymphoid organs. Nat Rev Immunol. 10:813–825. 2010.
View Article : Google Scholar : PubMed/NCBI
|
